Overall survival for women who received standard chemotherapy treatment plus bevacizumab was a median five months longer than for women who received the standard chemotherapy treatment alone.
Suscribirse a:
Enviar comentarios (Atom)
A word from the editor, news, information, reviews
No hay comentarios:
Publicar un comentario